COVID-19 vaccination with bacterial peptide conjugated to receptor-binding domain elicits potent immune response

In a recent study published in the iScience journal, researchers assessed the efficiency of immunization with a bacterial peptide conjugated to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor-binding domain against SARS-CoV-2 infection. Overall, the study findings showed that the CPD-RBD vaccination elicited a potent immune response and also protected against the severe symptoms associated with COVID-19.